Biomarker Discoveries in Gastric Precancerous Lesions
Explore groundbreaking biomarker discoveries in gastric precancerous lesions in this 37-minute conference talk from the 2022 Gastric Cancer Summit. Presented by Dr. Constanza Camargo from The National Cancer Institute, delve into the Early Detection Research Network's findings on gastric cancer. Examine the roles of pepsinogen, inflammation, and H. pylori serology in early detection. Investigate multiplex studies combining pepsinogen and serology techniques. Uncover insights on genetic susceptibility, microRNAs, and methylation in gastric cancer development. Analyze trends, hypotheses, and key results that shape our understanding of gastric precancerous lesions. Gain valuable knowledge to advance gastric cancer research and early detection strategies.